Einstein (São Paulo), 2021 Objective: To assess the quantitative serum levels of tropomyosin receptor kinase receptor B, and to estimate its association with serum concentration of brain-derived neurotrophic factor and obesity in patients with painful and painless forms of ...
Tamara Filimonova, Yulia Karakulova
doaj +2 more sources
Prevalent neuropathy in a cohort of HIV-infected Kenyan sex workers using antiretroviral drugs
The Pan African Medical Journal, 2016 INTRODUCTION: several risk factors including stavudine and age have been strongly associated with polyneuropathy. However, conflicting data exist on height as an independent risk factor in polyneuropathy.
Frank Ndaks Ndakala +5 more
doaj +1 more source
Case report: A novel variant in SLC25A46 causing sensorimotor polyneuropathy and optic atrophy
Frontiers in Neurology, 2022 SLC25A46 is a mitochondrial protein involved in mitochondrial dynamics. Recently, bi-allelic variants have been identified as a pathogenic cause in a spectrum of neurological syndromes.
Louise Sloth Kodal +5 more
doaj +1 more source
Polyneuropathy: how to diagnose?
Медицинский совет, 2016 Identifying the causes of polyneuropathy is a challenging clinical problem. Patients are often diagnosed with "polyneuropathy of unknown origin". At the same time, the etiological treatment of polyneuropathy is the most effective.
L. T. Akhmedzhanva
doaj +1 more source
AMPLITUDO SENSORY NEURON ACTION POTENTIAL USING AS INSTALLATION OF POLINEUROPATI DIAGNOSIS
Malang Neurology Journal, 2018 Background. Polyneuropathy is the pathologic changes and functional disturbances in the peripheral nervous system. These changes manifest as sign and symptoms such as numbness, burning, allodynia, atrophy, and lose of stimulation responses.
Billi Kinesya +3 more
doaj +1 more source
The prevalence and risk factors of diabetic polyneuropathy in inpatients with type 1 diabetes
Нервно-мышечные болезни, 2015 The NISLL scale and 7 electrophysiological tests were used to diagnose distal symmetric sensorimotor polyneuropathy in 120 inpatients with type 1 diabetes mellitus. The high rate (68.3%) of symptomatic or subclinical polyneuropathy was found.
I. A. Strokov +4 more
doaj +1 more source
Diet quality and chronic axonal polyneuropathy: a population‐based study
Annals of Clinical and Translational Neurology, 2019 Objective To investigate the association between diet quality and chronic axonal polyneuropathy. Methods Between June 2013 and January 2017, among 1650 participants of the Rotterdam Study (median age 69.1 years, 54.2% women), diet quality was quantified ...
Noor E. Taams +5 more
doaj +1 more source
Global Burden Related to Nitrous Oxide Exposure in Medical and Recreational Settings: A Systematic Review and Individual Patient Data Meta-Analysis. [PDF]
, 2019 The risk of adverse effects of nitrous oxide (N2O) exposure is insufficiently recognized despite its widespread use. These effects are mainly reported through case reports. We conducted an individual patient data meta-analysis to assess the prevalence of
Filhine-Tresarrieu, Pierre +10 more
core +3 more sources
A machine learning-based severity prediction tool for diabetic sensorimotor polyneuropathy using Michigan neuropathy screening instrumentations [PDF]
arXiv, 2022 Background: Diabetic Sensorimotor polyneuropathy (DSPN) is a major long-term complication in diabetic patients associated with painful neuropathy, foot ulceration and amputation. The Michigan neuropathy screening instrument (MNSI) is one of the most common screening techniques for DSPN, however, it does not provide any direct severity grading system ...
arxiv
Regulators of angiogenesis in chemotherapy-induced peripheral neuropathy
Alʹmanah Kliničeskoj Mediciny, 2022 Background: Chemotherapy-induced peripheral polyneuropathy is a major neurotoxicity of treatment for acute lymphoblastic leukemia (ALL) in children.
Vladimir V. Bazarnyi +4 more
doaj +1 more source